FDA Cites Two Compounders for Quality Control Issues

Drug Industry Daily
A A
The FDA has faulted two compounders for neglecting to apply quality controls to the production of their sterile drugs, pummeling one of the compounders with 13 citations.

To View This Article:

Login

Subscribe To Drug Industry Daily